EVER Pharma Jena GmbH

Contact

• email: jena(at)everpharma.com
• Internet: www.everpharma.com/de/
• Location: Otto-Schott-Str. 15, D-07745 Jena
• Legal representative: Herr Dr. Wolfgang Schmitzberger (Geschäftsführer), Herr Georges Kahwati (Geschäftsführer), Frau Dr. Manuela Pfeifer (Geschäftsführerin)

Object

the research, development, manufacture and distribution of medicinal products, products assimilated to medicinal products and novel products, diagnostics and chemical-technical products

Activities

- Production and packaging of high-quality complex injection preparations such as crystal suspensions, oily solutions, highly oxygen-reduced preparations, implants in vials, ready-to-fill syringes, cartridges and ampoules - Processing of highly active substances such as hormones, cytostatics and controlled substances on appropriately designed modern equipment - Worldwide supply of EVER Pharma products as well as for third-party customers - Pharmaceutical services (full service for the production and testing of sterile dosage forms; support in development and dossier preparation)

Products

- aseptic or terminally sterilised sterile liquid preparations in ampoules, vials and pre-filled syringes - crystal suspensions - hormone products - sterile implants - anaesthetics - oily solutions -- highly oxygen-reduced injection solutions

Further information

- Takeover of Jenapharm (formerly part of VEB Jenapharm, founded in 1950) by pharmaceutical wholesaler GEHE AG (1991). - Takeover by Schering AG (1996). - Takeover of sterile production at the Jena site by HEXAL AG and company name as a subsidiary under JENAHEXAL Pharma GmbH (2001). - JENAHEXAL becomes part of the Sandoz Division within the Novartis Group (2005/06). - Takeover of the sterile production JENAHEXAL by EVER Pharma GmbH and company name as a subsidiary under EVER Pharma Jena GmbH (2011). - Investment of over €200 million in state-of-the-art production facilities for injectable products in Jena by EVER Pharma (2015-2021).

Certificates

EU-GMP Directive 2003/94/EC, ISO 14001, GCC (MENA), CFDA (China), ANVISA (Brazil), RU-GMP (Russia), KFDA (South Korea), TDMDA (Turkey), NDA (Uganda), UAE (United Emirates) and PDMA (Japan)

Sectors

Life Sciences Thuringia

Pharmaceutical preparations
Manufacturers of pharmaceutical products
Pharmaceuticals